Another new manufacturing site for NC; BioCentriq acquired by South Korean company
Enzyvant will expand its regenerative medicine manufacturing with a new facility in North Carolina’s Research Triangle Park area.
The building of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
